AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 81 min read$AXON

Coughlin Elizabeth Reid sold $754K of AXON

Coughlin Elizabeth Reid (Chief Human Officer) sold 1,554 shares of AXON ENTERPRISE, INC. (AXON) at $485.00 ($0.75M total) on 2026-06-04.

Original reporting
SEC EDGAR · Coughlin Elizabeth Reid
Published Jun 8, 2026, 8:59 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 8, 2026, 9:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$AXON
Neutral
high confidence
Mentioned
$AXON
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AXONNeutralLow
01

Why it matters

It documents an officer’s open-market sale; it does not provide new operational, financial, or legal information about Axon.

02

Market read

Traders may note the insider sale, but there is no new company catalyst to drive a sustained repricing.

03

What to watch

Insider sales can be driven by diversification, tax, or personal liquidity needs; without additional filings (buys, options exercises, or material events), signal quality is low.

Relevance 5/10Novelty 2/10Timing: Filed 2026-06-08; sale executed 2026-06-04.

Background

The article is a SEC Form 4 insider transaction disclosure for Axon Enterprise, Inc.

Company-level read

Ticker impact

$AXONNeutralHigh confidence
Context

Axon chief human officer Elizabeth Reid filed an open-market sale of 1,554 shares at $485/share on 2026-06-04 (Form 4).

Expected impact

Low near-term impact; any reaction is likely muted and short-lived.

Evidence & confidence

This is a Form 4 insider transaction with no 10b5-1 plan and no accompanying fundamental disclosure (no guidance, contract, or enforcement action).

Market effects

Sector

Minimal; insider sale does not change sector fundamentals or regulatory outlook.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The absence of a 10b5-1 plan could be interpreted as discretionary selling, but the disclosed size is still small relative to typical institutional flows.

Key entities

  • issuer
    AXON ENTERPRISE, INC.

    Company whose insider transaction was reported on SEC Form 4.

  • insider
    Coughlin Elizabeth Reid

    Chief Human Officer who sold 1,554 shares at $485/share.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

AXON insider trading history →

Related articles

SEP 18
$AXONHighAI 9/10

Axon’s (AXON) Dilution Fears Look Overstated

Axon Enterprise (AXON) stock fell after announcing a $1B convertible-note offering, but analysts argue dilution fears are overstated. The notes carry 0% interest, convert at $652.06, and are hedged to $1,049.94. Q2 revenue rose 35% to $904M, marking 10 straight quarters of over 30% growth. Management raised full-year revenue growth outlook to 32-34%. AXON has a Strong Buy consensus rating, with an average price target of $719.55.

tipranks.com2 min
SEP 18
$AXONHighAI 8/10

Why Did Axon Stock Fall Ten Percent On A Convertible That Pays No Interest?

Axon Enterprise (AXON) shares dropped 9.8% after announcing a $1.0 billion convertible note offering with a 0% coupon. The market interpreted this as a sign of cash flow challenges despite strong revenue growth (34.6% YoY). The company cited inventory investments and rising component costs. AXON's stock is now 43% below its 52-week high, trading at 11x trailing revenue with shrinking margins.

yahoo.com2 min
SEP 18
$AXONHighAI 9/10

Axon Q2FY26 Results: Revenue rises 35% to $904 million, guidance raised

Axon Enterprise reported Q2FY26 revenue of $904M, up 35% YoY, and raised full-year guidance to 32-34% growth. Software & services revenue rose 36% to $398M, while connected devices revenue grew 35% to $507M. Platform solutions revenue surged 123% to $150M. The company plans a $1B convertible note offering due 2031, with net proceeds for general corporate purposes and capped call transactions. Shares were up 0.50% in premarket trading.

scanx.trade3 min
SEP 18
$AXONHighAI 8/10

Full Transcript: Axon Enterprise Q2 2026 Earnings Call - (AXON)

Axon Enterprise (AXON) reported a record Q2 2026 with 39% growth, driven by demand for Dedrone, Taser 10, and Axon Body 4. The company raised its full-year revenue guidance to 32-34% growth, citing strong bookings and market expansion. Management highlighted investments in AI and public safety technologies, emphasizing trust and data privacy.

benzinga.com2 min
SEP 18
$AXONMedAI 8/10

Axon Rebounded 6% Wednesday. Here’s What Could Drive the Stock Through 2026

Axon Enterprise's stock rebounded 6% to $468 on Wednesday after a 10% drop following a $1 billion convertible notes offering. The company expects 32-34% revenue growth in 2026, with strong Q4 growth anticipated. Analysts maintain bullish targets, citing Axon's faster expansion compared to competitors like Motorola Solutions. The stock has an implied upside of 56% based on a valuation model target of $706.

tikr.com2 min